Cover Image

Early Diagnosis of COPD —How Can we Do Better?

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Shawn D. Aaron
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Respirology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Asthma‐COPD overlap and asthma progressing to COPD: Are we using the right diagnostic approaches and pathways?
by: Elvis Malcolm Irusen, et al.
Published: (2024)

An Important Step Towards Better Health Management for People With COPD
by: Brian J. Smith
Published: (2026)

Asthma‐COPD overlap and asthma progressing to COPD: A complementary perspective
by: Christine F. McDonald, et al.
Published: (2024)

Missing Millions With COPD
by: John R. Hurst
Published: (2025)

Breathless and heart broken in COPD
by: John R. Hurst
Published: (2024)

COPD: The forgotten cardiovascular risk
by: Belinda Cochrane
Published: (2024)

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
by: Chin Kook Rhee, et al.
Published: (2025)

Transforming recruitment to clinical trials in COPD
by: Tanya Patrick, et al.
Published: (2024)

Rebranding COPD Care and Research in the 21st Century
by: Joan B. Soriano, et al.
Published: (2025)

Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
by: Fanny Wai San Ko, et al.
Published: (2026)

Is there a role for chest wall mobilization in the management of COPD?
by: Annemarie L. Lee, et al.
Published: (2024)

Pulmonary function testing in COPD: Anchoring clinical relevance
by: Bruce R. Thompson
Published: (2024)

Validation and Further Analysis of the COPD Exacerbation Recognition Tool ( CERT )
by: Xiangju Xing, et al.
Published: (2025)

Form Is Function: Predicting COPD Outcomes With Respiratory Muscle Dysfunction
by: Bartolome R. Celli
Published: (2025)

Airway Mucus Plugs in COPD : A Potential Treatable Trait
by: Naoya Tanabe
Published: (2025)

COPD is associated with increased cardiovascular disease risk independent of phenotype
by: Kolton Cobb, et al.
Published: (2024)

Respiratory health effects of cannabis—How should we respond to liberalization of cannabis laws?
by: Robert J. Hancox
Published: (2024)

Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs
by: Syed Ahmar Shah
Published: (2025)

Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk
by: Ibrahim Nagmeldin Hassan
Published: (2025)

Turning Limitations Into Insights: The Path Forward for COPD and Cardiovascular Risk Research
by: Paula Rodriguez‐Miguelez, et al.
Published: (2025)

Treatable traits—Where we are, where we are headed
by: Vanessa Marie McDonald, et al.
Published: (2024)

High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD
by: Nobuyasu Wakazono, et al.
Published: (2025)

Epigenetic Scarring and a Vulnerable Mucus–Barrier Axis in Ex‐Smokers With COPD
by: Mitsuo Sato
Published: (2026)

Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap
by: Chantal Donovan
Published: (2025)

Seeing the Unseen: Cell Population Data Reveal Distinct Inflammatory Phenotypes in Severe COPD
by: Makoto Ishii
Published: (2025)

Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”
by: Junyi Bai, et al.
Published: (2025)

Reply to ‘Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”’
by: Nobuyasu Wakazono, et al.
Published: (2025)

Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbations
by: Charles Wong, et al.
Published: (2026)

Is fractional exhaled nitric oxide ready to be a biomarker? Within‐day variability in stable COPD
by: Inès Van Rossem, et al.
Published: (2024)

Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
by: Shyamali C. Dharmage, et al.
Published: (2024)

CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life
by: Hao Wang, et al.
Published: (2025)

Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET
by: Hendrik Pott, et al.
Published: (2024)

Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis
by: Xinru Ran, et al.
Published: (2025)

Breathomics Analysis for Early Diagnosis of Lung Cancer Based on PTR ‐ TOF MS : A Large Sample Size Cross‐Sectional Study
by: Yan Huang, et al.
Published: (2026)

Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD : Evidence from NHANES 2011–2018”
Published: (2024)

Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial
by: Amy Ying Yu Tsui, et al.
Published: (2024)

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease ( GOLD ) and the Global Initiative for Asthma ( GINA )
by: David M. G. Halpin, et al.
Published: (2026)

Characterising Patient Pathways Prior to the Diagnosis of Interstitial Lung Disease
by: Caitlin C. Fermoyle, et al.
Published: (2026)

Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE‐BUILD) pilot study
by: Laura M. Glenn, et al.
Published: (2024)

Non‐Intubated VATS for Interstitial Lung Disease Diagnosis: A Safer Technique or Too Soon to Tell?
by: Nathan J. Mortimer, et al.
Published: (2025)